Showing 1 - 2 results of 2 for search 'Isabelle Raimbaud', query time: 0.04s Refine Results
  1. 1
    NY-ESO-1-specific circulating CD4+ T cells in ovarian cancer patients are prevalently T(H)1 type cells undetectable in the CD25+ FOXP3+ Treg compartment.

    NY-ESO-1-specific circulating CD4+ T cells in ovarian cancer patients are prevalently T(H)1 type cells undetectable in the CD25+ FOXP3+ Treg compartment. by Nassima Redjimi, Karine Duperrier-Amouriaux, Isabelle Raimbaud, Immanuel Luescher, Danijel Dojcinovic, Jean-Marc Classe, Dominique Berton-Rigaud, Jean-Sébastien Frenel, Emmanuelle Bourbouloux, Danila Valmori, Maha Ayyoub

    Published 2011-01-01
    Get full text
    Article
  2. 2
    Antibody responses to NY-ESO-1 in primary breast cancer identify a subtype target for immunotherapy.

    Antibody responses to NY-ESO-1 in primary breast cancer identify a subtype target for immunotherapy. by Ahmed Hamaï, Karine Duperrier-Amouriaux, Pascale Pignon, Isabelle Raimbaud, Lorenzo Memeo, Cristina Colarossi, Vincenzo Canzonieri, Tiziana Perin, Jean-Marc Classe, Mario Campone, Pascal Jézéquel, Loïc Campion, Maha Ayyoub, Danila Valmori

    Published 2011-01-01
    Get full text
    Article

Search Tools: